Taken together, experimental models demonstrate that S1R activation by pridopidine improves motor and psychiatric symptoms and promotes molecular pathways commonly impaired in NDD, such as calcium signaling, mitochondrial function, BDNF expression, integrity of dendritic spines, and transcriptional factors [1, 10, 13, 17, 40]. Here, BDNF is linked to Neurodevelopmental delay.